Stock Price
2.05
Daily Change
-0.06 -2.84%
Monthly
-14.94%
Yearly
-1.44%
Q1 Forecast
2.07

Mesoblast reported $1.28B in Ordinary Share Capital for its fiscal semester ending in June of 2025.





Ordinary Share Capital Change Date
Clinuvel Pharmaceuticals AUD 168.8M 754.23K Jun/2024
Cochlear AUD 65.4M 1.12B Dec/2025
CSL USD 482.13M 93.87M Dec/2025
Pacific Edge NZD 1.02B 210.22M Dec/2025
Paradigm Biopharmaceuticals AUD 389.43M 136.19M Jun/2025
PYC Therapeutics AUD 597.24M 366.66M Dec/2025
Ramsay Health Care AUD 229.93M 2.04B Dec/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Starpharma Holdings AUD 419.92M 179.17M Dec/2025
Telix Pharmaceuticals AUD 338.78M 379K Dec/2025